||Registry of biomedical companies:
   [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Z] 563 active entries
10900 University Boulevard, MS 1J2
United States of America, Virginia
Toll free: 800-615-0418
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
Ceres was founded to take advantage of the huge potential of the Nanotrap technology. The Nanotrap technology has been in development for almost four years as part of a collaboration between George Mason University (see below) and Italy's ISS (Istituto Superiore di Sanitá). In early 2008, Ceres obtained an exclusive license from George Mason University to develop commercial applications for various market segments, together with a first right of refusal on developed applications as they are discovered at the University. Ceres is currently raising capital and is at the nascent stages of business development and lab operations build-out, with much of its R&D being conducted at the George Mason University campus in Innovation Park, Manassas.
Last update of this entry: February 12, 2009